Thromboelastography
Thromboelastography (TEG) is a method used for testing the efficiency of blood coagulation. It is a test that measures the viscoelastic properties of blood under shear stress. It was invented by Helmut Hartert in 1948 while working at the University of Heidelberg.
History[edit]
Helmut Hartert invented thromboelastography in 1948 while working at the University of Heidelberg. The method was further developed and commercialized by Hartert's student, Hellmut Mehnert, and his company, Haemoscope Corporation.
Method[edit]
Thromboelastography measures the viscoelastic properties of blood under shear stress. It is used to assess the speed of clot formation, the stability of the clot, and the process of clot dissolution. The test is performed by placing a sample of blood in a heated cup, which is then rotated at a constant speed. The rotation causes the blood to clot, and the viscoelastic properties of the clot are measured by a torsion wire.
Clinical use[edit]
Thromboelastography is used in various clinical settings, including cardiac surgery, liver transplantation, and trauma care. It is also used to monitor the effects of anticoagulant therapy.
See also[edit]
References[edit]
-
Thromboelastography mechanics
-
Thromboelastography parameters
-
Normal thromboelastography
-
Thromboelastography in hemodilution or clotting factor deficiency
-
Thromboelastography in fibrinogen deficiency
-
Thromboelastography in low or dysfunctional platelets
-
Thromboelastography in thrombosis
-
Thromboelastography in primary fibrinolysis
-
Thromboelastography in secondary fibrinolysis
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
